RSSL, a leading Life Sciences Contract Research Organization (CRO) and ERBC, a specialist in preclinical research and regulatory studies, have announced a strategic partnership designed to deliver integrated, end-to-end drug development support for pharmaceutical and biotech clients worldwide.
Coulter Partners, the global expert in building leadership teams for Health, Science and Technology innovation businesses, is proud of the successful placement of Valerio Ferri as Chief Executive Officer (CEO) at ExoLab Italia.
In this interview, we speak with Abby Clark, the BIA's Manufacturing Programme Manager, who shares her personal journey from a degree-level apprenticeship to a key policy role.
Logical Biological, biospecimen and critical raw material leader based at Discovery Park, and Bcell Design, pioneers in transgenic monoclonal antibody technology, today announced a long term strategic international partnership to deliver engineered disease state materials for diagnostic and research markets.
Coulter Partners successfully completed a search assignment for the Cell and Gene Therapy Catapult (CGT Catapult) and is pleased to announce the placement of Dr. Ed Samuel as Chief Operations Officer (COO).
Discovery Park, Kent’s thriving life science and innovation community, today welcomed eight promising cardiovascular and cardiometabolic health startups to its campus. The cohort are embarking on the ‘Discovery Spark’ business growth programme, championing and supporting early stage business working on innovations in heart health.
Startup Festival Attendee Guide
